HAS2 and polycystic ovary syndrome: Recent studies found that the HAS2 mRNA level is lower in GCs of polycystic ovary syndrome (PCOS) patients than in those of controls14, and is highly upregulated in human GCs treated with human chorionic gonadotropin (hCG)15.